Stay updated on Pembrolizumab in Recurrent Respiratory Papilloma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Recurrent Respiratory Papilloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Recurrent Respiratory Papilloma Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.2 to v3.6.3. This indicates a newer version of the study page has been published.
    Difference
    0.1%
    Check dated 2026-07-03T22:15:52.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The page's revision indicator was updated from v3.6.0 to v3.6.2, indicating a newer revision of the page content.
    Difference
    0.1%
    Check dated 2026-06-27T00:00:56.000Z thumbnail image
  4. Check
    33 days ago
    Change Detected
    Summary
    The study page now shows No longer looking for participants, indicating recruitment has closed. New or updated help and navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study) along with a standardized Intervention/Treatment label and a new revision note (Revision: v3.6.0).
    Difference
    0.5%
    Check dated 2026-06-12T14:41:45.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.5.4 to v3.5.5, indicating a newer version of the page/document.
    Difference
    0.1%
    Check dated 2026-06-05T09:16:03.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.5.3 to v3.5.4, indicating a new version of the page was published. This update does not alter the study content or layout beyond the version reference.
    Difference
    0.1%
    Check dated 2026-05-15T04:52:46.000Z thumbnail image
  7. Check
    76 days ago
    Change Detected
    Summary
    The study record now marks the trial as Completed, replacing the prior Active, not recruiting status. The update includes date stamps and a revision tag (v3.5.3), indicating documentation updates associated with completion.
    Difference
    0.6%
    Check dated 2026-04-30T18:53:00.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Recurrent Respiratory Papilloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Recurrent Respiratory Papilloma Clinical Trial page.